Cargando…
The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial
IMPORTANCE: The Mobile Health Technology for Improved Screening and Optimized Integrated Care in Atrial Fibrillation (mAFA-II) trial is a prospective cluster randomized trial that found a significant reduction in the composite clinical outcome of stroke or thromboembolism, all-cause death, and rehos...
Autores principales: | Yao, Yuan, Guo, Yutao, Lip, Gregory Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693229/ https://www.ncbi.nlm.nih.gov/pubmed/34932104 http://dx.doi.org/10.1001/jamanetworkopen.2021.40071 |
Ejemplares similares
-
Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort
por: Guo, Yutao, et al.
Publicado: (2022) -
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort
por: Guo, Yutao, et al.
Publicado: (2020) -
Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023) -
Efficacy of mobile health-technology integrated care based on the ‘Atrial fibrillation Better Care’ (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023) -
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Guo, Yutao, et al.
Publicado: (2020)